Skylar is an associate editor for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®, and joined AJMC® in 2020. She is responsible for covering all aspects of the ever-changing global biosimilar industry and produces content that is accessible and informative for all health care stakeholders.
She has a BA in journalism and media studies from Rutgers University. You can connect with Skylar on LinkedIn.
Vitamin D Provides Therapeutic Benefit Among Patients With MM, Review Says
June 15th 2022A literature review revealed that supplementation with vitamin D could provide therapeutic benefits for patients with multiple myeloma (MM) who are undergoing chemotherapy. However, more research is needed to confirm findings.
Read More
AACR Posters Demonstrate CGP for Biomarker Detection and Multiomics Profiling
June 11th 2022Posters from the American Association of Cancer Research (AACR) Annual Meeting demonstrated the use of genomic profiling and sequencing can detect immunotherapy biomarkers and predict clinical outcomes in patients with cancer.
Read More
The Challenges of Living With Narcolepsy While Pregnant and How Providers Can Help
June 8th 2022A panel of providers and patients with narcolepsy who are parents shared the struggles and possible support tools that neurologists and other providers should be aware of when caring for patients with narcolepsy who are pregnant or postpartum.
Read More
Idiopathic Hypersomnia Needs More Attention to Overcome Challenges Regarding Diagnosis and Treatment
June 8th 2022During her presentation at SLEEP 2022, Isabelle Arnulf, MD, PhD, a neurologist and professor, detailed the long list of challenges for understanding different aspects of idiopathic hypersomnia and called for more attention to be devoted to future research.
Read More
In Keynote Address, Dr Susan Redline Refutes Report Claiming CPAP May Not Improve Health Outcomes
June 7th 2022Susan Redline, MD, MPH, the SLEEP 2022 meeting keynote speaker, catalogued the evidence proving that continuous positive airway pressure (CPAP) does improve health outcomes—refuting a recent controversial report that claims otherwise.
Read More
Race Is Not a Risk Factor for Disrupted Sleep, but Racism Is
June 6th 2022A panel of experts at the SLEEP 2022 conference argued against considering race a risk factor for health complications and disrupted sleep, saying that being on the receiving end of racial discrimination is the true risk factor.
Read More
Abstracts Highlight Association Between Idiopathic Hypersomnia and Weight, Social Relationships
June 5th 2022Posters from the SLEEP 2022 conference revealed some of the interaction between idiopathic hypersomnia and different aspects of life, including weight changes and interpersonal relationships.
Read More
Dr Sharon Phares Lists the Many Factors Physicians Should Consider When Choosing Therapies
May 18th 2022Sharon Phares, PhD, MPH, chief scientific officer of the National Pharmaceutical Council, explained the importance of taking multiple factors into consideration when making health care decisions.
Read More
Dr Sharon Phares Speaks on How Value Assessments Can Improve Care Imbalances for Women
May 13th 2022Marking Women's Health Month, Sharon Phares, PhD, MPH, chief scientific officer of the National Pharmaceutical Council, detailed how value assessments can address health care imbalances for women.
Read More
Higher Diabetes Risk at Lower Weight, Younger Age for Racial, Ethnic Minorities vs White People
May 9th 2022Black, Asian, and Hispanic adults in the United States were found to have an increased risk for developing diabetes at lower weights and younger ages compared with White Americans, suggesting that screening recommendations for the disease should be altered to reflect this difference.
Read More
Dr Soumya Vishwanath Highlights Tools for Assessing the Effectiveness of Digital Therapeutics
May 4th 2022Health plans and payers have plenty of options for how to analyze the effectiveness of digital therapeutic tools, as there are several effective strategies, according to Soumya Vishwanath, PharmD, of Magellan Rx Management.
Read More
Dr Gillian Woollett Highlights International Markets With Successful Biosimilar Adoption
April 29th 2022Gillian Woollett, MA, Dphil, vice president and head of regulatory strategy and policy at Samsung Bioepis, gives insight into what international markets the United States could look to as examples of good biosimilar adoption.
Read More
NPC's Michael Ciarametaro on How Clinics Can Surmount Gene Therapy Data Collection Barriers
April 22nd 2022Michael Ciarametaro, MBA, vice president of research at the National Pharmaceutical Council, highlights steps clinics can take to mitigate issues related to data collection regarding cell and gene therapies.
Read More
Incremental Hemodialysis Provides Better Savings, Same Outcomes as Standard Hemodialysis
April 16th 2022Researchers found that implementing an incremental schedule for hemodialysis in patients with residual kidney disease produced similar clinical outcomes and significant savings for health systems compared with hemodialysis administered on a more traditional schedule.
Read More
Expert: Better Harmony Is Needed to Prevent Compromised Specimens During CGP Testing
April 15th 2022Despite technological advancements, there are still many factors that can cause specimens for comprehensive genomic profiling (CGP) testing to become compromised, potentially leading to inaccurate prognostic results, according to a recent webinar.
Read More
New Minimal Residual Disease Assessment Could Detect Disease Progression Earlier in MM
April 11th 2022Flow–minimal residual disease (MRD) assessment in patients with multiple myeloma (MM) was found to be a good tool for early detection of MRD and could aid providers in treatment decision-making.
Read More
Several Factors Contribute to Impaired Fertility in Women, Men With CKD
April 8th 2022A literature review outlined the number of fertility complications that men and women with chronic kidney disease (CKD) face as well as the list of potential factors that can impact fertility and sexual functions in this population.
Read More
Equivalent Safety, Efficacy Between Herceptin and Trastuzumab Biosimilar for Gastric Cancer
April 7th 2022A trastuzumab biosimilar was found to have similar safety and efficacy with the reference product (Herceptin) in patients with advanced gastric cancer, a population previously excluded from bioequivalence studies for trastuzumab biosimilars.
Read More
Dr Chelsee Jensen on the Solution to Stocking Multiple Biosimilars for the Same Reference Product
April 7th 2022Chelsee Jensen, PharmD, pharmaceutical formulary manager at the Mayo Clinic, provides her take on why practices will have to continue to stock multiple biosimilars for the same reference product.
Read More
What Can Payers Do to Improve Biosimilar Uptake? Ryan Haumschild, PharmD, Weighs In
April 2nd 2022Ryan Haumschild, PharmD, MS, MBA, director of pharmacy services at Emory Healthcare and Winship Cancer Institute, explains how payers can play an essential role in improving biosimilar adoption.
Read More
What Dr Zahra Mahmoudjafari Wishes Payers Knew About CAR T-Cell Therapies
April 1st 2022Zahra Mahmoudjafari, PharmD, BCOP, clinical pharmacy manager at the University of Kansas Health System, gives her take on what payers should keep in mind when dealing with chimeric antigen receptor (CAR) T-cell therapies.
Read More
Katie Lockhart Details How the Specialty Drug Pipeline Is Expected to Affect Payers
April 1st 2022Pipeline forecasting can provide payers better insight into which expensive specialty drugs coming down the pipeline they should be keeping their eyes on, according to Katie Lockhart, MA, manager at Magellan Health.
Read More